Recursion Pharmaceuticals... (RXRX)
5.86
0.13 (2.27%)
At close: Apr 28, 2025, 3:59 PM
5.81
-0.91%
After-hours: Apr 28, 2025, 07:59 PM EDT
Recursion Pharmaceuticals Revenue
Recursion Pharmaceuticals reported an annual revenue of $58.84M, reflecting a 32% growth. For the quarter ending December 31, 2024, Recursion Pharmaceuticals generated $4.51M in revenue.
Revenue (ttm)
$58.84M
Revenue Growth
32%
Price / Sales Ratio
31.5
Revenue / Employee
$73.55K
Employees
800
Market Cap
2.32B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 58.84M | +32.00% |
| Dec 31, 2023 | 44.58M | +12.33% |
| Dec 31, 2022 | 39.68M | +296.81% |
| Dec 31, 2021 | 10M | +193.00% |
| Dec 31, 2020 | 3.41M | n/a |